[1]金　歌,马丽霞,王　丹,等.高颅压患者经中等长度静脉导管输注甘露醇注射液导管相关并发症的影响因素[J].新乡医学院学报,2021,38(10):940-943.[doi:10.7683/xxyxyxb.2021.10.008]
　JIN Ge,MA Lixia,WANG Dan,et al.Influencing factors of catheter-related complications in patients with intracranial hypertension treated with mannitol injection via midline catheter[J].Journal of Xinxiang Medical University,2021,38(10):940-943.[doi:10.7683/xxyxyxb.2021.10.008]
点击复制

高颅压患者经中等长度静脉导管输注甘露醇注射液导管相关并发症的影响因素
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年10
页码:
940-943
栏目:
临床研究
出版日期:
2021-10-05

文章信息/Info

Title:
Influencing factors of catheter-related complications in patients with intracranial hypertension treated with mannitol injection via midline catheter
作者:
金　歌1; 马丽霞1; 王　丹1; 田　林1; 王龙君1; 李亚南2
（1.郑州大学第一附属医院郑东院区重症医学部，河南　郑州　450052；2.郑州大学第一附属医院护理部，河南　郑州450052）
Author(s):
JIN Ge1; MA Lixia1; WANG Dan1; TIAN Lin1; WANG Longjun1; LI Yanan2
(1.Intensive Care Unit,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,Henan Province,China;2.Department of Nursing,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,Henan Province,China）
关键词:
中等长度静脉导管; 甘露醇注射液; 导管相关并发症
Keywords:
midline catheter; mannitol injection; catheter-related complications
分类号:
R472
DOI:
10.7683/xxyxyxb.2021.10.008
文献标志码:
A
摘要:
目的　探讨高颅压患者经中等长度静脉导管(MC)输注体积分数20%甘露醇注射液导管相关并发症的发生情况及影响因素。方法　回顾性分析郑州大学第一附属医院神经重症监护病房2019年11月至2020年8月经MC输注体积分数20%甘露醇注射液的909例高颅压患者的临床资料，按照输液期间是否发生导管相关并发症将患者分为并发症组与无并发症组，采用独立样本t检验或χ2检验对导管相关并发症相关因素进行单因素分析，二分类logistic回归分析对导管相关并发症相关因素进行多因素分析。结果　909例患者中，24例发生导管相关并发症，导管相关并发症发生率为2.64%；其中血凝性导管堵塞9例（0.90%），渗出6例（0.66%），静脉炎6例（0.66%，均为1级静脉炎），导管相关性血栓形成3例（0.33%）。单因素分析显示，经MC输注时间、MC尖端位置、MC留置时间与导管相关并发症的发生有关（P＜0.05）；年龄、性别、穿刺静脉、MC型号与导管相关并发症的发生无关（P>0.05）。logistic回归分析结果显示，MC尖端位置位于锁骨下静脉开口处是导管相关并发症的保护因素（OR=0.161，P＜0.05），MC留置时间＞28 d及经MC输注时间＞14 d是导管相关并发症的危险因素（OR=25.257、14.000，P＜0.05）。结论　高颅压患者置入MC输注体积分数20%甘露醇注射液时应将导管尖端位置达到锁骨下静脉开口处、导管留置时间控制在28 d内、输注时间应不超过14 d，以降低导管相关并发症的发生率。
Abstract:
Objective　To investigate the incidence of catheter-related complications of 20% mannitol injection through midline catheter(MC) in patients with intracranial hypertension and its influencing factors.Methods　The clinical data of 909 patients with intracranial hypertension treated with infusion of 20% mannitol injection via MC in the Neurological Intensive Care Unit of the First Affiliated Hospital of Zhengzhou University from November 2019 to August 2020 were analyzed retrospectively.The patients were divided into the group with complication and the group without complication according to whether cathe-ter-related complications occurred during infusion.The independent sample t-test or χ2 test were used for univariate analysis to analyze influencing factors of catheter-related complications,and binary logistic regression analysis was used for multivariate analysis to analyze influencing factors of catheter-related complications.Results　Among the 909 patients,24 patients had catheter-related complications,the incidence of catheter-related complications was 2.64%;among them,there were 9 cases (0.90%) of hemagglutinating catheter obstruction,6 cases (0.66%) of exudation,6 cases (0.66%) of phlebitis (grade 1 phlebitis),and 3 cases (0.33%) of catheter-related thrombosis.Univariate analysis showed that the time of MC infusion,position of MC tip and time of MC indwelling were related to the occurrence of catheter-related complications (P<0.05);the age,sex,puncture vein and MC model were not related to the occurrence of catheter-related complications (P>0.05).Binary logistic regression analysis showed that the position of MC tip at the opening of the subclavian vein was the protective factor for catheter-related complications（OR=0.161，P＜0.05）.The time of MC indwelling more than 28 days and the time of infusion viaMC more than 14 days were the risk factors of catheter-related complications（OR=25.257,14.000;P＜0.05).Conclusion　When patients with intracranial hypertension are implanted with MC for infusion of 20% mannitol injection,the MC tip should reach the opening of subclavian vein,the MC retention time should be within 28 days,and the infusion time of 20% mannitol injection should not exceed 14 days,so as to reduce the incidence of catheter-related complications.

参考文献/References:

［1］　中华医学会神经病学分会神经重症协作组,中国医师协会神经内科医师分会神经重症专业委员会.难治性颅内压增高的监测与治疗中国专家共识［J］.中华医学杂志,2018,98(45):3643-3652.
［2］　ALI A,TETIK A,SABANCI P A,et al.Comparison of 3% hypertonic saline and 20% mannitol for reducing intracranial pressure in patients undergoing supratentorial brain tumor surgery:a randomized,double-blind clinical trial［J］.J Neurosurg Anesthesiol,2018,30(2):171-178.
［3］　ADAMS D Z,LITTLE A,VINSANT C,et al.The midline catheter:a clinical review［J］.J Emerg Med,2016,51(3):252-258.
［4］　刘艺红,刘燕,邱晓燕.中等长度导管在神经内科病人中的应用及常见问题分析［J］.护理实践与研究,2009,6(20):102-103.
［5］　INFUSION NURSE SOCIETY.Infusion therapy standards of practice［J］.J Infus Nurs,2016,39(1Suppl):S1-S132.
［6］　段娟,李丹,程琳,等.神经外科重症病人导管相关性血栓的研究进展［J］.护理研究,2019,33(15):2651-2655.
［7］　LISOVA K,HROMADKOVA J,PAVELKOV K,et al.The incidence of symptomatic upper limb venous thrombosis associated with midline catheter:prospective observation［J］.J Vasc Access,2018,19(5):492-495.
［8］　中华神经科学会,中华神经外科学会.各类脑血管疾病诊断要点［J］.中华神经外科杂志,1997,13(1):3-5.
［9］　孙红,陈利芬,郭彩霞,等.临床静脉导管维护操作专家共识［J］.中华护理杂志,2019,54(9):1334-1342.
［10］　中国研究型医院学会护理分会项目组.中等长度静脉导管临床应用专家共识［J］.中华护理杂志,2020,55(S2):43-50.
［11］　窦启金,朱桂琴,马智敏.PDCA护理对肿瘤化疗患者PICC置管并发症与护理质量的影响［J］.护理实践与研究,2018,15(18):106-108.
［12］　邹晓春,何金爱,宋燕伶,等.252例留置静脉中长导管患者调查分析［J］.护理学报,2016,23(20):48-50.
［13］　CHOPRA V,KAATZ S,SWAMINATHAN L,et al.Variation in use and outcomes related to midline catheters:results from a multi-center pilot study［J］.BMJ Qual Saf,2019,28(9):714-720.
［14］　TRIPATHI S,KUMAR S,KAUSHIK S.The practice and complications of midline catheters:a systematic review［J］.Crit Care Med,2021,49(2):e140-e150.
［15］　成芳,傅麒宁,何佩仪,等.输液导管相关静脉血栓形成中国专家共识［J］.中国实用外科杂志,2020,40(4):377-383.
［16］　陈海燕,欧社娣,潘珊,等.改良中等长度PICC导管在老年慢性阻塞性肺疾病患者中的应用［J］.广东医学,2018,39(13):2048-2049.
［17］　CAMPAGNA S,GONELLA S,ZERLA P A,et al.The risk of adverse events related to extended-dwell peripheral intravenous access［J］.Infect Control Hosp Epidemiol,2018,39(7):875-877.
［18］　CAWCUTT K A,HANKINS R J,MICHEELS T A,et al.Optimizing vascular-access device decision-making in the era of midline catheters［J］.Infect Control Hosp Epidemiol,2019,40(6):674-680.
［19］　WEI T,LI X Y,YUE Z P,et al.Catheter dwell time and risk of catheter failure in adult patients with peripheral venous［J］.J Clin Nurs,2019,28(23-24):4488-4495.
［20］　任应国,张保朝,贾东佩,等.甘露醇联合神经节苷脂注射液治疗急性高血压脑出血疗效观察［J］.新乡医学院学报,2019,36(8):768-772.
［21］　任晓玲,陈亚娟,刘敬,等.超声监测在新生儿经皮外周静脉置入中心静脉导管尖端定位中的应用［J］.中华实用儿科临床杂志,2019,34(18):1398-1401.

更新日期/Last Update: 2021-10-05